6.14
price down icon3.91%   -0.25
after-market Handel nachbörslich: 6.26 0.12 +1.95%
loading

Pavmed Inc Aktie (PAVM) Neueste Nachrichten

pulisher
May 25, 2026

PAVmed Inc. (PAVM) reports Q1 loss, lags revenue estimates - MSN

May 25, 2026
pulisher
May 22, 2026

PAVM PE Ratio & Valuation, Is PAVM Overvalued - Intellectia AI

May 22, 2026
pulisher
May 22, 2026

Will PAVmed Inc. (PAVM) report negative earnings next week? What you should know - MSN

May 22, 2026
pulisher
May 22, 2026

PAVM|PAVmed Inc|Price:6.390|Chg%:0.04 - TradingKey

May 22, 2026
pulisher
May 20, 2026

Earnings call transcript: PAVmed Q1 2026 sees restructuring gains - Investing.com India

May 20, 2026
pulisher
May 20, 2026

Earnings call transcript: PAVmed Q1 2026 sees restructuring gains By Investing.com - Investing.com Australia

May 20, 2026
pulisher
May 20, 2026

Maxim Group Maintains PAVmed(PAVM.US) With Buy Rating, Maintains Target Price $16 - Moomoo

May 20, 2026
pulisher
May 20, 2026

PAVM Technical Analysis | Trend, Signals & Chart Patterns | PAVMED INC (NASDAQ:PAVM) - ChartMill

May 20, 2026
pulisher
May 19, 2026

PAVmed Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:PAVM) 2026-05-19 - Seeking Alpha

May 19, 2026
pulisher
May 18, 2026

PAVmed Inc earnings dates,PAVmed Inc earnings estimates - RTTNews

May 18, 2026
pulisher
May 17, 2026

Lucid Diagnostics Inc. (LUCD) reports Q1 loss, misses revenue estimates - MSN

May 17, 2026
pulisher
May 17, 2026

PAVmed Q1 2026 earnings preview - MSN

May 17, 2026
pulisher
May 16, 2026

PAVmed Inc. (NASDAQ:PAVM) Q1 2026 Earnings Call Transcript - Insider Monkey

May 16, 2026
pulisher
May 16, 2026

PAVmed Inc (PAVM) Q1 2026 Earnings Call Highlights: Strategic Re - GuruFocus

May 16, 2026
pulisher
May 15, 2026

PAVM Reports Strong Q1 Growth and Financial Position - GuruFocus

May 15, 2026
pulisher
May 15, 2026

PAVmed Inc (PAVM) Q1 2026 Earnings Call Highlights: Strategic Restructuring and Growth ... By GuruFocus - Investing.com Canada

May 15, 2026
pulisher
May 15, 2026

Two Seas Capital (NASDAQ: PAVM) Holds 9.99% of PAVmed, Including Warrants - Stock Titan

May 15, 2026
pulisher
May 15, 2026

PAVM: Restructuring completed; subsidiaries near major milestones and capital structure is simplified - TradingView

May 15, 2026
pulisher
May 15, 2026

PAVmed Inc.Common Stock (NQ: PAVM - FinancialContent

May 15, 2026
pulisher
May 15, 2026

PAVmed (PAVM) Q1 2026 Earnings Transcript - AOL.com

May 15, 2026
pulisher
May 15, 2026

PAVmed Releases Q1 2026 Financial Results - AlphaStreet

May 15, 2026
pulisher
May 15, 2026

PAVmed targets Varis FDA submission by end of 2026 while evaluating new assets following cap table cleanup - MSN

May 15, 2026
pulisher
May 15, 2026

PAVmed Q1 2026 Earnings Call Insights - Intellectia AI

May 15, 2026
pulisher
May 15, 2026

PAVmed (PAVM) Q4 2025 Earnings Transcript - The Globe and Mail

May 15, 2026
pulisher
May 15, 2026

PAVmed Reports Q1 2026 Financial Results, Highlights Progress in Veris Health FDA Submission and Lucid Diagnostics Commercial Expansion - Minichart

May 15, 2026
pulisher
May 15, 2026

PAVmed Reports Wider-than-Expected Q1 2026 Loss - AlphaStreet

May 15, 2026
pulisher
May 15, 2026

PAVmed Q1 2026 Earnings Call Transcript - Benzinga

May 15, 2026
pulisher
May 15, 2026

PAVM: Restructuring complete; subsidiaries advancing, with growth tied to capital and milestone achievements - TradingView

May 15, 2026
pulisher
May 15, 2026

Earnings call transcript: PAVmed Inc. Q1 2026 shows restructuring gains By Investing.com - Investing.com Nigeria

May 15, 2026
pulisher
May 15, 2026

PAVM: Restructuring enables growth, with Lucid and Veris advancing toward major milestones - TradingView

May 15, 2026
pulisher
May 15, 2026

Earnings call transcript: PAVmed Inc. Q1 2026 shows restructuring gains - Investing.com

May 15, 2026
pulisher
May 15, 2026

PAVmed (PAVM) Q1 2026: EPS $(4.42) Misses $(0.70) Estimate; Reve - GuruFocus

May 15, 2026
pulisher
May 15, 2026

PAVmed Inc. (PAVM) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance

May 15, 2026
pulisher
May 15, 2026

PAVmed Reports Q1 2026 Results and Business Update - TipRanks

May 15, 2026
pulisher
May 15, 2026

Q1 2026 PAVmed Inc Earnings Call Transcript - GuruFocus

May 15, 2026
pulisher
May 15, 2026

PAVmed (NASDAQ: PAVM) Q1 2026 results, losses and cash position - Stock Titan

May 15, 2026
pulisher
May 15, 2026

PAVmed Q1: cancer test and implantable monitor push toward coverage, FDA - Stock Titan

May 15, 2026
pulisher
May 15, 2026

PAVmed (PAVM) upgraded to buy: Here's what you should know - MSN

May 15, 2026
pulisher
May 14, 2026

PAVmed Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 14, 2026
pulisher
May 14, 2026

PAVmed Reports Business Expansion and Financial Update - Intellectia AI

May 14, 2026
pulisher
May 14, 2026

PAVM: Q1 2026 saw $1.3M revenue, improved adjusted loss, and a strengthened cash position into 2027 - TradingView

May 14, 2026
pulisher
May 14, 2026

PAVmed (NASDAQ: PAVM) posts Q1 2026 loss and flags going concern risks - Stock Titan

May 14, 2026
pulisher
May 14, 2026

First Manhattan group reports 9.6% stake in PAVmed (PAVM) - Stock Titan

May 14, 2026
pulisher
May 14, 2026

Lucid Diagnostics Inc.Common Stock (NQ: LUCD - FinancialContent

May 14, 2026
pulisher
May 14, 2026

Lucid Diagnostics Reports Q1 2026 Financial Results: $1.3M Revenue, Strong Cash Position, and Medicare Reimbursement Milestone Progress - Minichart

May 14, 2026
pulisher
May 14, 2026

Lucid Diagnostics Provides Business Update and Reports First Quarter 2026 Financial Results - BioSpace

May 14, 2026
pulisher
May 14, 2026

Lucid Diagnostics Inc. (LUCD) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance

May 14, 2026
pulisher
May 14, 2026

Lucid Diagnostics Reports Q1 2026 Results and Outlook - TipRanks

May 14, 2026
ZBH ZBH
$84.41
price down icon 1.27%
STE STE
$216.27
price down icon 0.14%
PHG PHG
$26.94
price down icon 0.04%
$72.01
price down icon 0.12%
$64.18
price down icon 0.08%
EW EW
$87.54
price up icon 2.05%
Kapitalisierung:     |  Volumen (24h):